NCT00569907View on ClinicalTrials.gov

Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Diabetes Mellitus Type 2

Trial Locations (1)

55416

International Diabetes Center - Park Nicollet Health Services, Minneapolis

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

HealthPartners Institute

OTHER

NCT00569907 - Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide | Biotech Hunter | Biotech Hunter